Clinical Assessment and Diagnostic Methods
Bladder storage and emptying dysfunction can involve two distinct problems: difficulty storing urine and difficulty emptying the bladder. Accurate assessment is important because these problems may require different diagnostic procedures and treatment approaches. For patients with suspected neurogenic bladder, our medical service focuses on identifying functional abnormalities, evaluating relevant neurological factors, and assessing appropriate treatment options, including sacral neuromodulation (SNM).
Our diagnostic assessment covers bladder storage function, bladder emptying function, and possible structural or neurological causes.
The available diagnostic methods include:
- Kidney and bladder ultrasound: Evaluates the urinary tract and bladder.
- Urodynamic testing (cystometry): Measures bladder pressure during filling and emptying to identify detrusor overactivity, reduced detrusor activity, and abnormal storage pressure.
- Lumbosacral MRI: Helps investigate potential neurological or structural abnormalities affecting bladder control.
- Cystoscopy: Examines the urethra and bladder to identify structural abnormalities, including urethral strictures, bladder stones, and tumors.
- Post-Void Residual (PVR) Measurement: Measures the amount of urine remaining in the bladder after urination. A PVR below 100 mL is listed as a normal reference value on our website.
Not every patient requires all five examinations. The assessment approach depends on clinical symptoms, medical history, and initial examination findings.
Conditions and Patient Eligibility
Bladder storage and emptying dysfunction can present in different ways.
Bladder storage dysfunction may involve involuntary bladder contractions, urinary urgency, and urinary incontinence.
Bladder emptying dysfunction may involve difficulty initiating urination, incomplete bladder emptying, urinary retention, and increased post-void residual volume.
Neurogenic bladder is an important clinical category within this scope. It occurs when neurological conditions or injuries affect communication between the nervous system and the bladder.
Assessment may be relevant for patients experiencing:
- Neurogenic bladder associated with neurological disorders or injuries.
- Urinary retention and incomplete bladder emptying.
- Overactive bladder symptoms and urinary incontinence.
- Abnormal bladder pressure or impaired bladder compliance.
- Combined storage and emptying dysfunction.
Identifying whether symptoms are associated with neurological dysfunction, impaired detrusor activity, or structural obstruction is important when determining an appropriate treatment approach.
Treatment Options and SNM Evaluation
Treatment depends on the underlying cause, bladder function, symptom severity, and individual clinical findings.
| Treatment option | Application and clinical role |
|---|---|
| Clean Intermittent Catheterization | Used when bladder emptying is inadequate; involves repeated catheterization to drain urine |
| Sacral Neuromodulation (SNM) | Considered for selected patients with non-obstructive urinary retention or overactive bladder |
| Intravesical Botulinum Toxin Injection | Delivered into the detrusor muscle through cystoscopy to reduce involuntary bladder contractions; the reported effect typically lasts 6–9 months |
| Suprapubic Cystostomy | A drainage option for patients unable to perform intermittent catheterization or whose other treatments have failed |
Sacral Neuromodulation Evaluation
For suitable patients, SNM involves a staged evaluation process.
Stage 1: Test Stimulation
- The test stimulation period typically lasts 7–14 days.
- Patient response is evaluated through voiding diaries, changes in urinary retention or incontinence, and relevant urodynamic measurements.
- Symptom improvement of 50% or more is a commonly used reference threshold for considering permanent implantation.
Stage 2: Permanent Implantation
Patients who demonstrate a sufficient response during the test phase may be considered for permanent SNM implantation following clinical evaluation.
The test result is an important treatment-selection factor, but eligibility and the final treatment decision depend on individual medical assessment.
Medical Team and International Patient Services
Our medical service provides assessment and treatment coordination for patients with neurogenic bladder and related urinary dysfunction.
The clinical team includes urology specialists, neurourology specialists, and rehabilitation professionals. Our medical information identifies a deputy chief physician at the First Affiliated Hospital of Anhui Medical University, whose professional focus includes urinary control, neurourology, and pelvic floor disorders.
For international patients, available support includes:
- Remote preliminary medical record assessment.
- Review of existing imaging, urodynamic reports, and medical records.
- English-language communication support.
- Coordination of further clinical assessment and treatment.
- Remote follow-up and SNM parameter adjustment support for eligible patients after treatment.
Remote assessment helps determine whether further clinical evaluation may be appropriate. It does not replace a formal in-person diagnosis when one is required.
Request a Medical Assessment
If you are experiencing bladder storage or emptying dysfunction, or are referring a patient with suspected neurogenic bladder, you can submit existing medical records for an initial review.
Please include available urodynamic reports, ultrasound or MRI findings, post-void residual measurements, previous treatment records, and a brief description of current symptoms.
Our medical team can review the available information and advise on appropriate next steps for further assessment and potential treatment.
Hot Tags: bladder storage and emptying dysfunction, China, price, pricelist, quotation, cost, Bladder Dysfunction, Hydronephrosis, Intravesical Botulinum Toxin Therapy, neurogenic bladder electrode, neurogenic bladder stimulation system implant, Neurogenic Bladder Symptoms

